Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Vaccinations01:51

Vaccinations

Overview
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Recent COVID-19 Vaccination and Risk of SARS-CoV-2 Transmission.

JAMA network open·2026
Same author

COVID-19 Antiviral Treatment: Examining Knowledge, Access, Trust in Sources of Information and Willingness to Use Among Essential Workers: A Cross-Sectional Survey of Cohort Participants.

Health science reports·2026
Same author

Estimating the generation time for SARS-CoV-2 transmission using United States household data, December 2021-May 2023.

Scientific reports·2026
Same author

The impact of viral and host factors on the influenza A virus transmission bottleneck.

PLoS pathogens·2026
Same author

Post-MIS-C cardiovascular outcomes: a systematic review.

European journal of pediatrics·2026
Same author

Applying capture recapture methods to estimate the burden of chlamydial and gonococcal infections using Indian Health Service Medical Records, 2016-2021.

American journal of epidemiology·2026

相关实验视频

Updated: Jul 15, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

在美国使用肺炎球菌合疫苗进行常规儿童免疫接种后,肺炎入院病例的减少:一个时间序列分析.

Carlos G Grijalva1, J Pekka Nuorti, Patrick G Arbogast

  • 1Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, TN 37212, USA.

Lancet (London, England)
|April 10, 2007
PubMed
概括

七价肺炎球菌合疫苗 (PCV7) 显著减少了美国两岁以下儿童的肺炎住院病例. 这种疫苗可以预防的疾病减少突显了常规婴儿免疫计划的影响.

更多相关视频

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
06:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

相关实验视频

Last Updated: Jul 15, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
06:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

科学领域:

  • 儿童传染病 儿童传染病
  • 疫苗学 疫苗学 疫苗学
  • 公共卫生监督是对公共卫生的监督.

背景情况:

  • 常规婴儿免疫接种七价肺炎球菌合疫苗 (PCV7) 在2000年在美国实施.
  • 虽然侵袭性肺炎球菌病减少,但对肺炎入院病人的影响仍未得到量化.

研究的目的:

  • 评估PCV7疫苗接种计划对幼儿所有原因和肺炎球菌性肺炎住院率的影响.

主要方法:

  • 在1997-2004年全国住院患者样本 (美国) 上使用中断时间序列分析.
  • 观察到的肺炎入院率 (2001-2004) 与疫苗接种前 (1997-1999) 年预测的比率进行了比较.
  • 评估脱水接收率作为控制结果.

主要成果:

  • 到2004年,两岁以下儿童的全因性肺炎病例减少了39%,每年预防大约41,000例病例.
  • 在同一个年龄组,肺炎球菌性肺炎的入院人数下降了65%.
  • 脱水接收率保持稳定,表明疫苗影响的特异性.

结论:

  • 观察到所有原因的肺炎病例的减少估计了美国儿童肺炎的疫苗可预防的比例,这是由Streptococcus pneumoniae引起的.
  • 研究结果支持肺炎球菌结合疫苗在儿童群体中的显著公共卫生益处.